Calprotectin levels correlated with VAS disease activity (β = 0.31, p = 0.01, Fig. 2f), duration of morning stiffness in patients with poly-articular gout (β = 0.71, p < 0.01, Fig. 2e), and inflammation marker CRP (β = 0.23, p = 0.05, Fig. 2g). The gene discussed is CRP; the disease is gout.